- Regional Meeting, Cambridge 18 May 2018
Regional Meeting, Cambridge 18 May 2018
The 2018 Regional Meeting will be held at Addenbrooke’s on Friday 18 May. The organisers are Dr Pippa Corrie and Dr Christine Parkinson of Cambridge University Hospitals NHS Foundation Trust.
CPD accreditation from the RCP, RCS and BAPRAS is being applied for.
Follow > this link < for information on meeting fees and how to register.
Welcome and Introduction
Professor Marc Moncrieff, Norfolk and Norwich University NHS Foundation Trust:
Update on national melanoma database
Session 1: Genetic predisposition, patterns of relapse and early detection of melanoma
Dr Erik Larsson Lekholm, Cancer Research UK Cambridge Institute:
Melanoma risk assessment and UV exposure
Dr Roy Rabbie, Wellcome Sanger Institute:
Prognostic factors and predictors of patterns of recurrence
Dr Jonathan Wan, Cancer Research UK Cambridge Institute:
Early detection of melanoma with ctDNA
Session 2: Immune checkpoint toxicity
Patient experience – immune checkpoint GI toxicity
Dr Tim Raine, Cambridge University Hospitals NHS Foundation Trust:
Case presentation of immune checkpoint GI toxicity
Dr Trevor Lawley, Wellcome Sanger Institute:
Immune checkpoint GI toxicity and the microbiome
Discussion of management of GI checkpoint inhibitor toxicities
Controversies in metastatic melanoma systemic therapy 1:
Should pre-existing auto-immunity or treatment-induced irAEs influence subsequent use of checkpoint inhibitors?
Session 3: Melanoma trials
Dr Jeffrey Weber, NYU Langone Medical Center, Perlmutter Cancer Center:
Adjuvant treatment of melanoma
Controversies in metastatic melanoma systemic therapy 2:
How should we schedule targeted therapy and checkpoint inhibitors?
Professor Poulam Patel, Chair, NCRI Skin CSG:
Update on the NIHR melanoma trials portfolio
Session 4: Surgical management of resectable disease
Mr Howard Peach, Leeds Teaching Hospitals NHS Trust:
Summary and Close